查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825430

2025年全球瘢痕疙瘩治療市場報告

Keloids Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年瘢瘢痕疙瘩治療市場將穩定成長，到2029年將達到50.9億美元，複合年成長率為4.2%。預測期內的成長歸因於個人保健產品支出的增加、政府舉措、對瘢痕預防策略的重視程度的提高以及瘢痕疙瘩治療領域的投資。預測期內的主要趨勢包括治療方法的進步、醫療技術的創新、更先進的蟹足腫瘢痕疙瘩治療技術、聯合治療、雷射技術和疤痕管理產品。

未來五年4.2%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會影響美國從美國和韓國進口的矽膠片和冷凍治療設備，這可能導致疤痕治療效果惡化，並增加皮膚科手術的成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，其影響可能會更加廣泛。

傷口和損傷發生率的增加預計將推動瘢痕疙瘩治療市場的成長。傷口是一種物理傷害或身體組織損傷，通常涉及由各種因素引起的皮膚斷裂，例如事故、手術、燒燙傷和其他創傷事件。傷口的增加會導致瘢痕疙瘩的形成，從而推動對有效治療方案的需求，提高人們對瘢痕疙瘩相關併發症的認知，刺激研究進步，並促進醫療專業人員之間的合作。例如，根據美國政府機構美國勞工統計局 2023 年 12 月的數據，預計 2022 年美國致命工傷人數將達到 5,486 人，比 2021 年的 5,190 人增加 5.7%。這一上升趨勢凸顯了工傷人數的顯著增加。因此，傷口和損傷發生率的增加預計將推動瘢痕疙瘩治療市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球瘢痕疙瘩治療：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球瘢痕疙瘩治療市場：成長率分析
  • 全球瘢痕疙瘩治療市場表現：規模與成長，2019-2024
  • 全球瘢痕疙瘩治療市場預測：規模與成長，2024-2029年，2034年
  • 全球瘢痕疙瘩治療：總目標市場（TAM）

第6章 市場細分

  • 全球瘢痕疙瘩治療市場：依治療、表現及預測，2019-2024 年、2024-2029 年、2034 年
  • 放射治療
  • 冷凍療法
  • 手術治療
  • 雷射治療
  • 類固醇注射
  • 干擾素
  • 其他治療
  • 全球瘢痕疙瘩治療市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 彈性包裹
  • 噴
  • 軟膏
  • 奶油
  • 油
  • 外用凝膠和凝膠片
  • 其他產品
  • 全球瘢痕疙瘩治療市場（依給藥途徑、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 腸外
  • 全球瘢痕疙瘩治療市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 居家護理
  • 皮膚科診所
  • 其他最終用戶
  • 全球瘢痕疙瘩治療市場：放射線治療類型細分、績效及預測（2019-2024、2024-2029、2034）
  • 術後放射線治療
  • 術前放射線治療
  • 全球瘢痕疙瘩治療市場：冷凍療法細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 冷凍手術
  • 冷凍消融
  • 全球瘢痕疙瘩治療市場：依手術治療（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 切除
  • 再次手術
  • 全球瘢痕疙瘩治療市場：依雷射治療類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 飛梭雷射
  • 脈衝染料雷射
  • 全球瘢痕疙瘩治療市場：類固醇注射細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 曲安奈德
  • Betamethasone
  • 全球瘢痕疙瘩治療市場：干擾素干擾素（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • α干擾素
  • 干擾素γ
  • 全球瘢痕疙瘩治療市場：依其他治療方法細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 矽膠片
  • 局部治療

第7章 區域和國家分析

  • 全球瘢痕疙瘩治療市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球瘢痕疙瘩治療市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 瘢痕疙瘩治療市場：競爭格局
  • 瘢痕疙瘩治療市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • AstraZeneca plc
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Mylan NV
  • Galderma SA
  • Sun Pharmaceutical Industries Ltd.
  • Molnlycke Health Care AB
  • Cynosure Inc.
  • Cutera Inc.
  • Alliance Pharma plc
  • Revance Therapeutics Inc
  • Sensus Healthcare
  • Strata Skin Sciences
  • Avita Medical Limited
  • Pacific World Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年瘢痕疙瘩治療市場：提供新機會的國家
  • 2029 年瘢痕疙瘩治療市場：細分領域帶來新機會
  • 2029年瘢痕疙瘩治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28378u

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.

The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The keloids treatment market size has grown steadily in recent years. It will grow from $4.14 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.

The forecast of 4.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. access to silicone gel sheets and cryotherapy devices imported from Germany and South Korea, potentially worsening scar management outcomes and increasing dermatology procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of wounds and injuries is expected to drive the growth of the keloid treatment market. A wound is a physical injury or damage to the body's tissues, typically involving a break in the skin, caused by various factors such as accidents, surgeries, burns, or other traumatic events. The rise in wound occurrences contributes to keloid formation, heightening the demand for effective treatment options, boosting awareness of keloid-related complications, encouraging research advancements, and fostering collaboration among medical professionals. For instance, in December 2023, data from the Bureau of Labor Statistics, a U.S. government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, representing a 5.7% increase from 5,190 in 2021. This upward trend highlights a substantial rise in industrial accidents. Consequently, the growing incidence of wounds and injuries will drive expansion in the keloid treatment market.

Growing interest in non-surgical aesthetic procedures is expected to drive the keloid treatment market. Non-surgical aesthetics are cosmetic treatments aimed at enhancing appearance without surgery, addressing specific concerns for a more youthful look. Healthcare providers utilize non-surgical procedures like laser therapy, cryotherapy, and dermal fillers to minimize the appearance and symptoms of keloid scars, reducing inflammation, redness, and vascularization. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a U.S.-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, marking an 11.2% increase overall. Consequently, the rising demand for non-surgical aesthetic procedures will propel the keloid treatment market forward.

Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.

In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.

Major companies operating in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.

North America was the largest region in the keloids treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Keloids Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on keloids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for keloids treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The keloids treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment: Radiation Therapy; Cryo Therapy; Surgical Treatment; Laser Treatment; Steroid Injections; Interferon; Other Treatments
  • 2) By Product Type: Elastic Wraps; Sprays; Ointment; Creams; Oils; Topical Gels And Gel Sheets; Other Products
  • 3) By Route Of Administration: Oral; Parenteral
  • 4) By End User: Hospitals; Homecare; Dermatology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiation Therapy: Post-Surgical Radiation Therapy; Pre-Surgical Radiation Therapy
  • 2) By Cryo Therapy: Cryosurgery; Cryoablation
  • 3) By Surgical Treatment: Excision; Revision Surgery
  • 4) By Laser Treatment: Fractional Laser; Pulsed Dye Laser
  • 5) By Steroid Injections: Triamcinolone Acetonide; Betamethasone
  • 6) By Interferon: Interferon-Alpha; Interferon-gamma
  • 7) By Other Treatments: Silicone Gel Sheets; Topical Treatments
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca plc; GlaxoSmithKline plc.; Eli Lilly and Company; Mylan N.V.; Galderma S.A.; Sun Pharmaceutical Industries Ltd.; Molnlycke Health Care AB; Cynosure Inc.; Cutera Inc.; Alliance Pharma plc; Revance Therapeutics Inc; Sensus Healthcare; Strata Skin Sciences; Avita Medical Limited; Pacific World Corporation; Mederma; Stratpharma AG; Sonoma Pharmaceuticals Inc.; RXi Pharmaceuticals Inc.; Biodermis; Novoxel Ltd.; Scar Heal Inc.; Galena Biopharma Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Keloids Treatment Market Characteristics

3. Keloids Treatment Market Trends And Strategies

4. Keloids Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Keloids Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Keloids Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Keloids Treatment Market Growth Rate Analysis
  • 5.4. Global Keloids Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Keloids Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Keloids Treatment Total Addressable Market (TAM)

6. Keloids Treatment Market Segmentation

  • 6.1. Global Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiation Therapy
  • Cryo Therapy
  • Surgical Treatment
  • Laser Treatment
  • Steroid Injections
  • Interferon
  • Other Treatments
  • 6.2. Global Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastic Wraps
  • Sprays
  • Ointment
  • Creams
  • Oils
  • Topical Gels And Gel Sheets
  • Other Products
  • 6.3. Global Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • 6.4. Global Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare
  • Dermatology Clinics
  • Other End Users
  • 6.5. Global Keloids Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Post-Surgical Radiation Therapy
  • Pre-Surgical Radiation Therapy
  • 6.6. Global Keloids Treatment Market, Sub-Segmentation Of Cryo Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cryosurgery
  • Cryoablation
  • 6.7. Global Keloids Treatment Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Excision
  • Revision Surgery
  • 6.8. Global Keloids Treatment Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fractional Laser
  • Pulsed Dye Laser
  • 6.9. Global Keloids Treatment Market, Sub-Segmentation Of Steroid Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Triamcinolone Acetonide
  • Betamethasone
  • 6.10. Global Keloids Treatment Market, Sub-Segmentation Of Interferon, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interferon-Alpha
  • Interferon-gamma
  • 6.11. Global Keloids Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Silicone Gel Sheets
  • Topical Treatments

7. Keloids Treatment Market Regional And Country Analysis

  • 7.1. Global Keloids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Keloids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Keloids Treatment Market

  • 8.1. Asia-Pacific Keloids Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Keloids Treatment Market

  • 9.1. China Keloids Treatment Market Overview
  • 9.2. China Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Keloids Treatment Market

  • 10.1. India Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Keloids Treatment Market

  • 11.1. Japan Keloids Treatment Market Overview
  • 11.2. Japan Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Keloids Treatment Market

  • 12.1. Australia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Keloids Treatment Market

  • 13.1. Indonesia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Keloids Treatment Market

  • 14.1. South Korea Keloids Treatment Market Overview
  • 14.2. South Korea Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Keloids Treatment Market

  • 15.1. Western Europe Keloids Treatment Market Overview
  • 15.2. Western Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Keloids Treatment Market

  • 16.1. UK Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Keloids Treatment Market

  • 17.1. Germany Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Keloids Treatment Market

  • 18.1. France Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Keloids Treatment Market

  • 19.1. Italy Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Keloids Treatment Market

  • 20.1. Spain Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Keloids Treatment Market

  • 21.1. Eastern Europe Keloids Treatment Market Overview
  • 21.2. Eastern Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Keloids Treatment Market

  • 22.1. Russia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Keloids Treatment Market

  • 23.1. North America Keloids Treatment Market Overview
  • 23.2. North America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Keloids Treatment Market

  • 24.1. USA Keloids Treatment Market Overview
  • 24.2. USA Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Keloids Treatment Market

  • 25.1. Canada Keloids Treatment Market Overview
  • 25.2. Canada Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Keloids Treatment Market

  • 26.1. South America Keloids Treatment Market Overview
  • 26.2. South America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Keloids Treatment Market

  • 27.1. Brazil Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Keloids Treatment Market

  • 28.1. Middle East Keloids Treatment Market Overview
  • 28.2. Middle East Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Keloids Treatment Market

  • 29.1. Africa Keloids Treatment Market Overview
  • 29.2. Africa Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Keloids Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Keloids Treatment Market Competitive Landscape
  • 30.2. Keloids Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Keloids Treatment Market Other Major And Innovative Companies

  • 31.1. AstraZeneca plc
  • 31.2. GlaxoSmithKline plc.
  • 31.3. Eli Lilly and Company
  • 31.4. Mylan N.V.
  • 31.5. Galderma S.A.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Molnlycke Health Care AB
  • 31.8. Cynosure Inc.
  • 31.9. Cutera Inc.
  • 31.10. Alliance Pharma plc
  • 31.11. Revance Therapeutics Inc
  • 31.12. Sensus Healthcare
  • 31.13. Strata Skin Sciences
  • 31.14. Avita Medical Limited
  • 31.15. Pacific World Corporation

32. Global Keloids Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Keloids Treatment Market

34. Recent Developments In The Keloids Treatment Market

35. Keloids Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Keloids Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Keloids Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Keloids Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer